Browse stocks · Browse sectors · Healthcare · Healthcare · Pharmaceuticals & Biotechnology · Pharmaceuticals

NSE RESEARCH WORKSPACE

Neuland Laboratories Ltd

NSE: NEULANDLAB

OverviewFinancial StatementsQuant ScoreForensic Accounting+

Price1Y

Company Overview

Neuland Laboratories Ltd is classified in Pharmaceuticals.

Market Cap: ₹ 24,203.59 Cr.
Price in snapshot: ₹ 18,865
ROE: 21.41 %
ROCE: 25.3 %
Dividend Yield: 0.18 %

Snapshot updated 22 July 2026. Figures are not live quotes.

Research coverage

Concall documents: transcript for Q1 FY27, dated 10 August 2026.
Annual-report coverage: FY2026.
Company exchange-filing catalog coverage.

Browse concall documents · Browse exchange filings